MO4-1 EGFR inhibitor upregulates HER3 expression and enhances the efficacy of anti-HER3 antibody drug conjugate U3-1402

Autor:	Hidetoshi Hayashi, Yuuri Hashimoto, Kenji Hirotani, Kazuko Sakai, Hiroki Goto, Hisato Kawakami, Kazuhiko Nakagawa, Maki Kobayashi, Osamu Maenishi, Masanori Funabashi, Masayuki Takeda, Kazuto Nishio, Ryoto Yoshimoto, Takashi Kagari, Junko Tanizaki, Kaoru Tanaka, Kimio Yonesaka
Rok vydání:	2021
Předmět:	Antibody-drug conjugate Oncology business.industry Cancer research Medicine Hematology business EGFR inhibitors
Zdroj:	Annals of Oncology. 32:S296
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::802c50a408e5bb68c35b898d102caff1 https://doi.org/10.1016/j.annonc.2021.05.567 Zobrazit plný text záznamu